Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of fingolimod-associated macular edema.

× No keyword cloud information.

11 in total

1. Fingolimod-associated macular oedema.

Authors: Kirti Madhukar Jasani; Nazar Sharaf; David Rog; Tariq Aslam
Journal: BMJ Case Rep Date: 2017-06-15

Review 2. The Ocular Manifestations of Drugs Used to Treat Multiple Sclerosis.

Authors: Gregory Heath; Archana Airody; Richard Peter Gale
Journal: Drugs Date: 2017-03 Impact factor: 9.546

3. Late Onset Macular Oedema in a Patient with Multiple Sclerosis Treated with Fingolimod.

Authors: Anna Camós-Carreras; Salut Alba-Arbalat; Marina Dotti-Boada; Alba Parrado-Carrillo; Carolina Bernal-Morales; Albert Saiz; Bernardo Sánchez-Dalmau
Journal: Neuroophthalmology Date: 2020-10-06

Review 4. Fingolimod: therapeutic mechanisms and ocular adverse effects.

Authors: P Mandal; A Gupta; W Fusi-Rubiano; P A Keane; Y Yang
Journal: Eye (Lond) Date: 2016-11-25 Impact factor: 3.775

5. Continuing fingolimod after development of macular edema: A case report.

Authors: Vivien Li; Jack Kane; Helen H L Chan; Anthony J Hall; Helmut Butzkueven
Journal: Neurol Neuroimmunol Neuroinflamm Date: 2014-05-15

6. Fingolimod Associated Bilateral Cystoid Macular Edema-Wait and See?

Authors: Refik Pul; Alma Osmanovic; Holger Schmalstieg; Amelie Pielen; Kaweh Pars; Philipp Schwenkenbecher; Kurt Wolfram Sühs; Özlem Yildiz; Benedikt Frank; Martin Stangel; Thomas Skripuletz
Journal: Int J Mol Sci Date: 2016-12-14 Impact factor: 5.923

Review 7. Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges.

Authors: Horace Massa; Spyros Y Pipis; Georgios D Panos; Temilade Adewoyin; Athanasios Vergados; Sudeshna Patra
Journal: Clin Ophthalmol Date: 2019-09-10

Review 8. Ocular adverse events from pharmacological treatment in patients with multiple sclerosis-A systematic review of the literature.

Authors: Juliana Muñoz-Ortiz; Juliana Reyes-Guanes; Estefanía Zapata-Bravo; Laura Mora-Muñoz; Juan Antonio Reyes-Hurtado; Luis Octavio Tierradentro-García; William Rojas-Carabali; Marcela Gómez-Suarez; Alejandra de-la-Torre
Journal: Syst Rev Date: 2021-10-28

Review 9. Visual consequences of medications for multiple sclerosis: the good, the bad, the ugly, and the unknown.

Authors: Heather E Moss
Journal: Eye Brain Date: 2017-06-29

10. Fingolimod-associated macular edema controlled with nepafenac non-steroidal anti-inflammatory opthalmologic applications.

Authors: Rachel Husmann; John B Davies; Malik Ghannam; Brent Berry; Praful Kelkar
Journal: Clin Mol Allergy Date: 2020-03-12